Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 13 of 23

CSI Appoints Former Upjohn Senior Research Scientist Mary J. Ruwart, Ph.D. to Vice President of Research & Development (VP R&D) Further Expanding Its Team of Drug Development Specialists

Created on 2018-06-11 21:26:48

Cannabis Science Continues Building Its Team of Drug Development Experts with the Appointment of Ray R. Carr, R.Ph., to the Chief Operating Officer

Created on 2018-06-11 21:25:56

Cannabis Science Receives U.S. Federal Government CAGE/NCAGE Code Certification

Created on 2018-06-11 21:24:46

Cannabis Science, Inc. Announces New Symbol CBIS.OB

Created on 2018-06-11 21:23:52

Cannabis Science Inc. Reports on Prospective Life Saving Treatments for H1N1 Swine Flu and H5N1 Bird Flu in View of the Current Global Threat

Created on 2018-06-11 20:23:29

Cannabis Compounds Reduce Multi-Drug Resistant Infections

Created on 2018-06-11 20:22:26

Cannabis Science CFO Speaks at a Conference Sponsored By the Mexican Congress, A Political Debate on the Regulation of the Cannabis Plant in Mexico

Created on 2018-06-11 20:21:32

Cannabis Science, Inc. Announces 420 Commemorative Certificate Program

Created on 2018-06-11 20:20:34

Highly Specialized International FDA Regulatory Compliance Firm Signs With Cannabis Science to Prepare for Company's First Pre-Investigative New Drug (IND) Submission Package for Veterans PTSD Project

Created on 2018-06-11 19:39:02

Cannabis Science Sets Second FDA Drug Target on $20 Billion "Chronic Pain" Market Targeting the Huge Need for Safe Non-Addictive Non-Lethal Cannabis Based Medications

Created on 2018-06-11 19:37:22

Cannabis Science Officially Begins Its First Pre-IND FDA Application Process For Post Traumatic Stress Disorder (PTSD)

Created on 2018-06-11 19:36:07

Cannabis Science Moves Its FDA Clinical Trial Process Forward

Created on 2018-06-11 19:35:01

Cannabis Science Inc. Announces Advances In Its Analytical Lab Logistics

Created on 2018-06-11 19:33:53

Cannabis Science Announces Preliminary Results of Its Survey of Cannabis Use By Veterans and Others With Post Traumatic Stress Disorder (PTSD) "Listen to What Our Veterans Are Telling Us"

Created on 2018-06-11 19:32:55

Cannabis Science Inc. (CBIS) Announces Progress in Bringing the First Cannabis Based Medicine to Market Company Moving Towards Contracts and Licensing Agreements for Research and Development of New Medicines

Created on 2018-06-11 19:31:55

Today Cannabis Science Releases Updates To Its Website That Integrates General Public Communications With Recent Developments In Its Analytical, Clinical Research, and Commercial Production Divisions

Created on 2018-06-11 19:30:52

Cannabis Science President To Appear Today On StockGoodies.com Live Radio Show As Part of National Educational Series On The Ground-Breaking Science of Medical Cannabis At 8:30AM Eastern

Created on 2018-06-11 19:21:45

Cannabis Science Signs A New Non-Exclusive Commercial License Agreement with Rockbrook To Continue Its Strategic Partnership In The State Of Colorado

Created on 2018-06-11 19:20:17

Cannabis Science Announces Critical Cancer Patient Dr. Lynnice Wedewer, Ph.D., Cured Seven Times By Medical Cannabis

Created on 2018-06-11 19:19:19

American Scene Radio - The Money Show with Steve Crowley Live Interview With Cannabis Science President And CEO Dr. Robert Melamede, Ph.D. On Tuesday, June 28th 11:29 am Eastern Standard Time

Created on 2018-06-11 19:18:22

  • Start
  • Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.